Chengdu Easton Biopharmaceuticals (688513.SH): Ailamode tablets obtain drug registration certificate.
Yuandong Bio (688513.SH) announces the issuance of the drug registration certificate for Elamod tablets, a wholly-owned subsidiary of the company...
Chengdu Easton Biopharmaceuticals (688513.SH) announced that its subsidiary, Chengdu Shuode Pharmaceuticals Co., Ltd. (referred to as "Shuode Pharmaceuticals"), has recently received the Drug Registration Certificate issued by the National Medical Products Administration (referred to as "NMPA") for the drug "Elamod Tablets".
Elamod Tablets contain the active ingredient Elamod and are indicated for active rheumatoid arthritis. Elamod Tablets are classified as a Class B variety in the "National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalogue (2024)".
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
